# CALQUENCE

NDC: 0310-0512
Generic name: Acalabrutinib
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 20171031

FDA application: NDA210259

## Active ingredients

- ACALABRUTINIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-0512"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-0512
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd4835ef-e1bc-4997-a399-1ffa2556fbfe